AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

T Glip-M 500 Tablet ER

Prescription Icon
Prescription Required

Marketer

Intas Pharmaceuticals Ltd

Salt Composition

Metformin (500mg) + Teneligliptin (20mg)

Overview T Glip-M 500 Tablet ER

Metformin-Glipizide 500mg Extended-Release tablets combine two medications to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, and may lessen the risk of cardiovascular events. Metformin-Glipizide 500mg ER may be prescribed as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is personalized, factoring in individual health status, glycemic control, and concomitant medications. Consuming this medication with food minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under physician guidance. Effective blood sugar regulation significantly reduces the risk of future complications. Continued commitment to the prescribed diet and exercise plan is crucial. Lifestyle choices are integral to diabetes management. Commonly reported adverse effects include nausea, vomiting, diarrhea, abdominal discomfort, and cephalgia. Hypoglycemia is a potential risk, particularly when used with insulin or sulfonylureas; understanding its symptoms and management is essential. This medication isn't suitable for all individuals. Prior to initiating treatment, disclose any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption to your physician. Pregnant or lactating women should seek medical counsel before use. Inform your doctor of all medications being taken to ensure compatibility and safety. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Your physician will monitor renal function and blood glucose levels throughout treatment.

Primary Ingredients of T Glip-M 500 Tablet ER

No text provided. Please provide the text you wish me to rephrase.

Uses of T Glip-M 500 Tablet ER

Managing type 2 diabetes

Major Benefits of T Glip-M 500 Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer T Glip-M 500 Tablet ER with a meal.

Common Side effects of T Glip-M 500 Tablet ER:

  • Nausea
  • Vomiting
  • Headache
  • Hypoglycemia (low blood glucose level)
  • Diarrhea

How to use T Glip-M 500 Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take T Glip-M 500 Tablet ER with a meal.

How T Glip-M 500 Tablet ER works:

Extended-release T Glip-M 500 tablets contain a dual-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol ingestion and T Glip-M 500 Tablet ER is contraindicated due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release T Glip-M 500 mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release T Glip-M 500mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of T Glip-M 500 Tablet ER on driving ability is undetermined. Refrain from driving if you exhibit any symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Individuals with kidney impairment should use T Glip-M 500 Tablet ER cautiously; dosage modification may be necessary. Consult a physician for guidance. For patients with severely compromised kidney function, T Glip-M 500 Tablet ER is contraindicated. Routine monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Extended-release glimepiride 500 mg tablets (e.g., T Glip-M 500) pose a likely risk for individuals with hepatic impairment and are best avoided. Seek medical advice.

What if you forget to take T Glip-M 500 Tablet ER :

Should you forget a dose of T Glip-M 500 Tablet ER, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.

Facts to Know About T Glip-M 500 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on T Glip-M 500 Tablet ER

Using T Glip-M 500 Tablet ER as directed by your doctor is safe. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, upset stomach, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (hypoglycemia) may occur. Hypoglycemia is more likely if you're also taking insulin or sulfonylurea. Report any persistent issues to your doctor.
TGlip-M 500 Tablet ER typically doesn't cause low blood sugar (hypoglycemia). However, hypoglycemia can happen if you don't consume enough calories while using it. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These are more likely if you skip meals, drink alcohol, overexert yourself, or take other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of T Glip-M 500 Tablet ER. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) warrant immediate medical attention. Do not take other medications without your doctor's approval.
Patients allergic to any T Glip-M 500 Tablet ER component or excipient should not use it. This medication is also contraindicated in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
T Glip-M 500 Tablet ER can cause lactic acidosis (MALA), a rare but serious side effect characterized by excessive lactic acid in the blood. This risk is higher in patients with kidney disease, older adults, and those who consume large amounts of alcohol, hence its avoidance in these groups. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of T Glip-M 500 Tablet ER can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency can result in anemia, nerve damage, and symptoms such as tingling or numbness in the extremities, weakness, urinary issues, cognitive changes, and balance problems (ataxia). If you experience any of these, consult your physician for potential vitamin B12 level monitoring and supplementation.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
T Glip-M 500 Tablet ER
314
MRP 382
17% off